BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Cyclacel Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

  Cyclacel Pharmaceuticals, Inc., a biopharmaceutical leader in cell cycle checkpoint control developing innovative medicines based on cancer cell biology, announced second quarter financial results and provided a business update.

  August 9, 2023

   · 

  7 min read
• Pharm Country

  Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands and Italy

  Amarin Corporation plc announced pricing and reimbursement updates for VAZKEPA in the Netherlands and Italy.

  August 9, 2023

   · 

  5 min read
• Business

  Lumos Pharma Reports Second Quarter 2023 Financial Results, Provides Clinical Update

  Lumos Pharma, Inc., a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency through Phase 2 clinical trials, announced financial results for the second quarter ended June 30, 2023.

  August 9, 2023

   · 

  15 min read
• Business

  aTyr Pharma Announces Second Quarter 2023 Results and Provides Corporate Update

  aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, announced second quarter 2023 results and provided a corporate update.

  August 9, 2023

   · 

  10 min read
• Business

  MaxCyte Reports Second Quarter and Half-Year 2023 Financial Results and Updates Full Year 2023 Guidance

  MaxCyte, Inc. announced financial results for the second quarter and six months ended June 30, 2023.

  August 9, 2023

   · 

  14 min read
• Business

  Singular Genomics Reports Recent Highlights and Second Quarter 2023 Financial Results

  Singular Genomics Systems, Inc., a company leveraging novel next-generation sequencing and multiomics technologies to empower researchers and clinicians, highlighted recent corporate achievements and reported financial results for the second quarter ended June 30, 2023.

  August 9, 2023

   · 

  8 min read
• Business

  4D Molecular Therapeutics Reports Second Quarter 2023 Financial Results and Operational Highlights

  4D Molecular Therapeutics a clinical-stage biotherapeutics company harnessing the power of directed evolution for genetic medicines targeting large market diseases, reported second quarter 2023 financial results and provided operational highlights.

  August 9, 2023

   · 

  11 min read
• Genetown

  Morphic to Present at the Canaccord Genuity 43rd Annual Growth Conference

  Morphic Therapeutic announced that Praveen Tipirneni, M.D., President and Chief Executive Officer, will take part in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference on Thursday, August 10, 2023 at 11:30 AM ET.

  August 9, 2023

   · 

  1 min read
• Business

  89bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update

  89bio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, reported its financial results for the second quarter ended June 30, 2023.

  August 9, 2023

   · 

  9 min read
• Business

  STRATA Skin Sciences Reports Second Quarter 2023 Revenue

  STRATA Skin Sciences, Inc. announced financial results for the second quarter ended June 30, 2023.

  August 9, 2023

   · 

  12 min read